Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FRRM1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,517
Award facts
- Contract value 100% obligated
- $11,516.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,516.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 100 Unit Vials. The contract is a firm fixed-price delivery order with an ultimate completion date of February 9, 2026, and was issued without a set-aside designation, indicating the awardee competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes regional prime vendor contractors to supply comprehensive pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial performance capability within the federal pharmaceutical supply chain, with the company's established track record supporting multiple delivery orders across diverse therapeutic categories since October 2025. As a critical supplier under the PPV-G GEN V program—which extends through December 31, 2036—DMS Pharmaceutical Group is positioned to fulfill specialized pharmaceutical requirements for military healthcare operations globally, with its $499,999,999 ceiling value IDC authorized to support recurring medical supply needs across the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DR26FRRM1?
SPE2DR26FRRM1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FRRM1 worth?
The government has obligated $11,517 on SPE2DR26FRRM1.
Is contract SPE2DR26FRRM1 an order under another contract?
Yes. SPE2DR26FRRM1 is a delivery order under SPE2DR25D9238, an indefinite delivery contract.
Was contract SPE2DR26FRRM1 competed?
The extent of competition for SPE2DR26FRRM1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award